1. Home
  2. RVMDW vs NYMTM Comparison

RVMDW vs NYMTM Comparison

Compare RVMDW & NYMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • NYMTM
  • Stock Information
  • Founded
  • RVMDW 2014
  • NYMTM N/A
  • Country
  • RVMDW United States
  • NYMTM United States
  • Employees
  • RVMDW N/A
  • NYMTM 79
  • Industry
  • RVMDW
  • NYMTM Real Estate Investment Trusts
  • Sector
  • RVMDW
  • NYMTM Real Estate
  • Exchange
  • RVMDW Nasdaq
  • NYMTM Nasdaq
  • Market Cap
  • RVMDW N/A
  • NYMTM N/A
  • IPO Year
  • RVMDW N/A
  • NYMTM N/A
  • Fundamental
  • Price
  • RVMDW $0.18
  • NYMTM $25.15
  • Analyst Decision
  • RVMDW
  • NYMTM
  • Analyst Count
  • RVMDW 0
  • NYMTM 0
  • Target Price
  • RVMDW N/A
  • NYMTM N/A
  • AVG Volume (30 Days)
  • RVMDW 15.6K
  • NYMTM N/A
  • Earning Date
  • RVMDW 02-26-2025
  • NYMTM N/A
  • Dividend Yield
  • RVMDW N/A
  • NYMTM N/A
  • EPS Growth
  • RVMDW N/A
  • NYMTM N/A
  • EPS
  • RVMDW N/A
  • NYMTM N/A
  • Revenue
  • RVMDW $742,000.00
  • NYMTM N/A
  • Revenue This Year
  • RVMDW N/A
  • NYMTM N/A
  • Revenue Next Year
  • RVMDW N/A
  • NYMTM N/A
  • P/E Ratio
  • RVMDW N/A
  • NYMTM N/A
  • Revenue Growth
  • RVMDW N/A
  • NYMTM N/A
  • 52 Week Low
  • RVMDW $0.10
  • NYMTM N/A
  • 52 Week High
  • RVMDW $0.12
  • NYMTM N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • NYMTM 47.51
  • Support Level
  • RVMDW N/A
  • NYMTM $25.24
  • Resistance Level
  • RVMDW N/A
  • NYMTM $25.39
  • Average True Range (ATR)
  • RVMDW 0.00
  • NYMTM 0.09
  • MACD
  • RVMDW 0.00
  • NYMTM -0.01
  • Stochastic Oscillator
  • RVMDW 0.00
  • NYMTM 7.73

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About NYMTM New York Mortgage Trust Inc.

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.

Share on Social Networks: